Clinical Trials Logo

Filter by:
NCT ID: NCT06316700 Not yet recruiting - Healthy Aging Clinical Trials

A Pharmacokinetic Study of a Novel Nutritional Product on Healthy Men and Women

Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This study is a randomized, double-blind, placebo-controlled study of N=16 apparently healthy men and women. The purpose of this study is to examine the bioavailability of a health and wellness supplement.

NCT ID: NCT06316297 Recruiting - Acne Clinical Trials

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

Start date: April 5, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the trial is to evaluate the safety, efficacy and immunogenicity of one or two intramuscular injections of the Acne mRNA vaccine candidate at three dose levels in adult participants aged 18 to 45 years with moderate to severe acne in the US.

NCT ID: NCT06315907 Active, not recruiting - Eating Behavior Clinical Trials

Development and Validation of a Brief Food Noise Questionnaire

Start date: April 25, 2024
Phase:
Study type: Observational

The purpose of the research is to develop and test the reliability and validity of a brief questionnaire to measure food noise.

NCT ID: NCT06315881 Not yet recruiting - Clinical trials for Tobacco-Related Carcinoma

Informing Oral Nicotine Pouch Regulations to Promote Public Health

Start date: September 1, 2024
Phase: Phase 2
Study type: Interventional

This clinical trial evaluates the characteristics of oral nicotine pouches (ONPs) to determine if they are a comparable substitute to cigarette or smokeless tobacco (ST) products. ONPs contain nicotine but no tobacco and are used primarily by adult tobacco uses in the United States (US). ONPs are recognized by the Food and Drug Administration as having lower risk than combustible cigarettes and are approved as a modified risk tobacco product. While ONPs have lower toxic risk than other tobacco products, acute and longer term harm related to their use has not been studied. Information gathered from this study may identify product characteristics of ONPs that improve successful switching from high-risk cigarettes or ST to lower risk ONPs.

NCT ID: NCT06315829 Not yet recruiting - Infantile Spasms Clinical Trials

Artificial Intelligence-based Video Analysis to Detect Infantile Spasms

Start date: August 2024
Phase:
Study type: Observational

Infantile spasms are a type of seizure linked to developmental issues. Unfortunately, they are often misdiagnosed, causing delays in treatment. The purpose of this study is to develop a computer program that can reliably differentiate infantile spasms from similar, yet benign movements in videos. This computer program will learn from videos taken by parents of study participants. Quickly recognizing and treating infantile spasms is crucial for ensuring the best developmental outcomes.

NCT ID: NCT06315738 Recruiting - Clinical trials for Necrotizing Enterocolitis

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis

Start date: May 29, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

The primary objective of this study is to determine the safety and tolerability of two dose levels (0.5 mL/kg and 1.0 mL/kg) of once daily (QD) via IV route of administration of ST266 in treating patients with Bell's stage IIA or higher medical NEC by incidence of treatment emergent adverse events (TEAEs) and SAEs, with a secondary objective to assess preliminary efficacy of the same two dose levels (0.5 mL/kg and 1.0 mL/kg) of QD via IV route of administration of ST266 in treating patients with Bell's stage IIA or higher medical NEC.

NCT ID: NCT06315595 Recruiting - Prostate Neoplasm Clinical Trials

Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion

Start date: September 30, 2015
Phase:
Study type: Observational

This study evaluates contrast-enhanced MR angiography and contrast-enhanced MR perfusion imaging for the visualization of blood vessels and enhancing tissues with better spatial detail and improved temporal fidelity compared to current methods.

NCT ID: NCT06315582 Recruiting - Treatment Clinical Trials

Surgical Approach to Uterine Septum

Start date: March 11, 2024
Phase: N/A
Study type: Interventional

The objective of this study is to determine if the use of scissors without electrosurgery is superior to bipolar electrosurgery for resection of uterine septum. The investigators will be comparing procedure-level variables such as operative time, complications, and need for additional procedures.

NCT ID: NCT06315517 Recruiting - Healthy Adults Clinical Trials

Double Crossover Casein Type Tolerance Trial

Start date: April 20, 2024
Phase: N/A
Study type: Interventional

The investigators will recruit 45 fluid milk avoiding adults to participate in a five-week double-blind, double-crossover study in which the physiological responses to increasing doses of lactose-free (A1-rich milk), A2 milk, and lactose-free A2 milk will be explored.

NCT ID: NCT06315309 Not yet recruiting - Clinical trials for Myelodysplastic Syndromes

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

Start date: June 29, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test whether the combination of the drugs called tacrolimus (Tac), methotrexate (MTX) and new dosing strategy of another drug called (rabbit Anti-thymocyte Globulin [ATG]) will help prevent the development and/or improve severity of acute and/or chronic GVHD.